India · Delayed Price · Currency is INR Wockhardt Company Description
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally.
It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products.
The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy.
In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine, as well as offers insulin aspart regular and biphasic drug products.
Further, the company offers delivery devices for insulin, including DispoPen disposable pen and Mypen reusable pen.
Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1967 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,564 |
| CEO | Murtaza Khorakiwala |
Contact Details
Address: Wockhardt Towers Mumbai, Maharashtra 400051 India | |
| Phone | 91 24 0669 4444 |
| Website | wockhardt.com |
Stock Details
| Ticker Symbol | WOCKPHARMA |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE049B01025 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Habil Fakhruddin Khorakiwala | Founder and Executive Chairman |
| Dr. Murtaza Habil Khorakiwala | MD and Executive Director |
| Dr. Sachin Bhagwat | Chief Scientific Officer |
| Dr. Huzaifa Habil Khorakiwala | Executive Director |
| Deepak R. Madnani | Chief Financial Officer |
| Paresh Kajrolkar | Global Chief Internal Auditor and Chief Risk, Sustainability and Data Protection Officer |
| Om Narayan | Senior Vice President of Biotech Research & Development |
| Annapurna Das | President of India Business and Emerging Markets NCE |
| Sunil Soni | Senior Vice President of Biotechnology |
| Ajay Sahni | Managing Director of Wockhardt Bio AG and Pinewood Healthcare |